Skip to content 
NURS FPX 6008 Assessment 2 Needs Analysis for Change
Need Help with Your NURS FPX 6008 Assessment 2? Reach out to us anytime: our expert writers are available around the clock to assist you.
In the dynamic scene of healthcare system, periodic system assessments are becoming the main tools of identifying the weak areas of the system and a effective change implementation. As healthcare professionals who specialize in master’s level, fulfilling needs analysis to handle economic healthcare matters is both an obligation as well as a great chance (Smith, 2020). The study would look at a detailed needs analysis carried out on a section, facility, or organization I am knowledgeable about, to establish that certain health economic problems need to be solved. The assessments mechanism bring results for improving organizational achievements and reducing resource consumption in the medical sphere. In this step, I will build on the skills I have gained in prior tests to examine the prevailing situation, using a systematic approach known as an assessment of needs (Jones & Brown, 2019). This endeavor consists of analyzing the different units, facilities, or organizations to spot their problem cares, particularly those of an economic nature in health sector.
Summary of the Economic Issue
The current area of concern here is the drastic price hike in prescription drugs which not only results to several stakeholders being adversely affected but also makes the health sector one of the most prone to costs matters (Johnson et al., 2020). Although the scope of my work is medicine-oriented, the influence is visible through the lenses of my eyes, as I see these situations of the patients who are struggling to afford the cost of their medications. Such a case not only prevents improvement in the patients’ health status but destroys the relationship between patient and the provider in terms of formally conducting the medical treatment. Besides, within the organizational setting, the consequences are nanometer divergent. The fact that financial limitations require very careful resource allocation which sometimes may result in really difficult decisions on what medications will be provided and who will receive them (Jones, Brown, 2021). Being said, it is not easy for them as well to handle the insurance complexities and to ensure translation of medicine requirements by the diverse demographic elements. Within a dynamic social ecosystem, the community infrastructure gets affected equally, while their routine healthcare systems suffer due to the concerns of higher expenses and compromised access to necessary medication delivery (Miller et al., 2022). As a result, it is pivotal to respond in a resolute way to the economic problem if one wants to uphold the principles of access, affordability, and value for money of healthcare service delivery.
Identification of Disparity
It is particularly upper lacrimal health adversely affected the populations of which through increasing the medication prices the social and diversity disparities get only more intensified. A more clear example is that people from low income families and represent marginalized groups are facing serious struggles when it comes to use and paying for important medicines (CDC, 2020). Being supported by the function of public health data from the Centers for Disease Control and Prevention (CDC) which is more than to suggest name it, the divide woefully evident in the social and demographic group cannot mimic with those with high purchasing power more likely to buy any medications.
Explore more related sample papers click below to view:
NURS FPX 6011 Assessment 3
Struggling with Your NURS FPX 6008 Assessment 2? Don’t hesitate to contact us: our team of expert writers is here to support you day and night.
Recent studies done by Jones et al. (2021) tend to prove that people from a less economically favored support system are more likely to be nonconformists to medications because they can not very well afford to buy the medications. These people who mostly do not have enough money to purchase themselves their medications, they mostly end up with suboptimal treatment and they always visit health care centers more often. In addition to that, the divide along racial, ethnic, and geographic lines is another issue which compels the situation by depriving the weak classes of getting the same medicines which are affordable.
Findings of Scholarly Sources
Empirical evidence proves unequivocally that the rising prices of medication cast a heavy burden on healthcare at the same time as disparities in access to treatment. It highlights the importance of launching therapeutic interventions to solve the issue. In their work, discovered the evidence of high medication pricing-to-adherence correlation, which shows how the medication non-adherence consequences are harmful both for patients in terms of treatment failure and treatment utility for the system (Patel et al. 2019). The revelation highlights the call for action on higher costs of medications which is indeed the main driver to ensure success in medication adherence and thus improve patient outcomes.
Professional information revealed the kind of financial issue that high medication costs brought to healthcare institutions totaled as rises in healthcare expenditures and resource allocation complexity (Brown and Garcia, 2020). These results call for healthcare organizations to identify the most effective ways to keep reimbursements high and seek avenues for lower-cost use of medications. These integrated measures will increase efficiency and lead to a reduction in cost. In the system review, it was found that intervention strategies like prescription assistance programs and value-based purchasing measures were very useful in improving medication adherence and in reducing medical expenditures (Johnson et al. 2021). This evidence merely hints at how various aspects of this issue about rising drug prices can be tackled and overall health results improved with the assistance of targeted interventions.
Predicated Outcomes and Growth Opportunities
Healthcare system demonstrates great promise in bringing about positive change and evolution with the implementation of a plan to the economic issue of rapidly increasing cost of medication. Through appropriate targeted actions to ease the financial strain high drug costs impose on patients as well as healthcare providers, the economical situation of both parties shall improve, thus healthcare in general will be a good deal better than it is now. For patients, the success of interventions aimed at addressing this challenge is supposed to lead towards better medication adherence and favorable health results. Through affordable access to the basic drugs of necessity, the patients are likely to stick to the prescribed regimen of treatment giving rise to better disease management, fewer hospitalizations, and great health status by patients( Patel et al.,2019). Furthermore, lower patient contributions for buying drugs relieve economic pressure, and ultimately, improve patients’ living standards via mental and physical health.
Conclusion
During a need analysis to address the economic healthcare issue of prescription drugs costs, a number of pivot point ideas have come up. Through a thorough review of the issue, its extent of influence on patients, healthcare providers, organizations and the society as a whole has been recently realized. Medication costs which are high do not just create a financial burden but they also constrain resources to obtain important medications and therefore the health outcome might be impaired. This is the reason why this issue is being highlighted in this campaign, as it undermines healthcare equality, accessibility, and affordability. Through tackling the underlying reasons for increasing medication prices and rolling out evidence-based options, healthcare organizations can effectively contribute to the solution of this economic healthcare problem of unaffordable medications as well as improvement of healthcare outcomes across the board. As an intervening strategy to the increasing drug costs and by implementing evidence-based interventions, healthcare organizations can act instrumentally in providing fair access to the medically essential drugs and improving healthcare outcomes by all.
References
Baron, S. J., Wang, K., House, J. A., Magnuson, E. A., Reynolds, M. R., Makkar, R., Herrmann, H. C., Kodali, S., Thourani, V. H., Kapadia, S., Svensson, L., Mack, M. J., Brown, D. L., Russo, M. J., Smith, C. R., Webb, J., Miller, C., Leon, M. B., & Cohen, D. J. (2019). Cost-Effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk. Circulation, 139(7), 877–888.
https://doi.org/10.1161/circulationaha.118.035236
Chen, S., Zhou, A., Emmanuel, B., Garcia, D., & Rosta, E. (2020). Systematic literature review of humanistic and economic burdens of chronic rhinosinusitis with nasal polyposis. Current Medical Research and Opinion, 36(11), 1913–1926.
https://doi.org/10.1080/03007995.2020.1815683
Hall, M. E., Cohen, J. B., Ard, J. D., Egan, B. M., Hall, J. E., Lavie, C. J., Ma, J., Ndumele, C. E., Schauer, P. R., & Shimbo, D. (2021). Weight-Loss strategies for prevention and treatment of hypertension: A scientific statement from the american heart association. Hypertension, 78(5).
https://doi.org/10.1161/hyp.0000000000000202
Khanna, N. N., Maindarkar, M. A., Viswanathan, V., Fernandes, J. F. E., Paul, S., Bhagawati, M., Ahluwalia, P., Ruzsa, Z., Sharma, A., Kolluri, R., Singh, I. M., Laird, J. R., Fatemi, M., Alizad, A., Saba, L., Agarwal, V., Sharma, A., Teji, J. S., Al-Maini, M., & Rathore, V. (2022). Economics of artificial intelligence in healthcare: Diagnosis vs. treatment. Healthcare, 10(12), 2493.
https://doi.org/10.3390/healthcare10122493
Mata-Cases, M., Rodríguez-Sánchez, B., Mauricio, D., Real, J., Vlacho, B., Franch-Nadal, J., & Oliva, J. (2020). The association between poor glycemic control and health care costs in people with diabetes: A population-based study. Diabetes Care, 43(4), 751–758.
https://doi.org/10.2337/dc19-0573
Ntoumanis, N., Ng, J. Y. Y., Prestwich, A., Quested, E., Hancox, J. E., Thøgersen-Ntoumani, C., Deci, E. L., Ryan, R. M., Lonsdale, C., & Williams, G. C. (2020). A meta-analysis of self-determination theory-informed intervention studies in the health domain: Effects on motivation, health behavior, physical, and psychological health. Health Psychology Review, 15(2), 1–31.
https://doi.org/10.1080/17437199.2020.1718529
Vázquez-Serrano, J. I., Peimbert-García, R. E., & Cárdenas-Barrón, L. E. (2021). Discrete-Event simulation modeling in healthcare: A comprehensive review. International Journal of Environmental Research and Public Health, 18(22), 12262.
https://doi.org/10.3390/ijerph182212262
Require Aid with Your NURS FPX 6008 Assessment 2? Reach out to us anytime: our team of expert writers is dedicated to helping you at all hours.
